Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Polycystic ovary syndrome

is the cardiometabolic risk increased after menopause?

Alur-Gupta, Snigdha MD; Dokras, Anuja MD, PhD

doi: 10.1097/GME.0000000000001286
Clinical Corner: NAMS Practice Pearl
Buy

Although more commonly known for its fertility sequelae, dermatologic, metabolic, and psychological morbidities associated with polycystic ovary syndrome (PCOS) are not well recognized. This Practice Pearl reviews the effect of PCOS on cardiometabolic risk during the reproductive years and the consequence of these findings in middle-aged women. Current screening and management recommendations are reviewed.

Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania.

Received 11 October, 2018

© 2019 by The North American Menopause Society.